Tag:
GenMark Diagnostics
Latest Headlines
Latest Headlines
For GenMark, more flu was good news in 2012
Thanks in part to a really nasty flu season, GenMark Diagnostics ended 2012 with a big boost in revenue.
GenMark's revenue soars as loss narrows
GenMark Diagnostics posted a four-fold revenue jump in the third quarter, as the company increased its analyzer placements and boosted its reagent sales by almost 5 times.
2012: A lackluster year for medical device and diagnostics IPOs
Put lightly, it was less than a banner year for medical device and diagnostics companies looking to go public. Check out the report >>
GenMark Diagnostics seeks $42M in public offering
Plans call for using the proceeds to expand test offering menu options and accelerate other product development. But the big focus here with the cash infusion will be to grow U.S. and global commercial operations.
GenMark IPO price range lowered
Pasadena, California-based GenMark Diagnostics recently announced that its initial public offering of 4.6 million shares of its common stock has been priced at $6 per share. However, as Reuters
